A Phase 2 Study of Abemaciclib in Patients With Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma
收藏DataCite Commons2025-11-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006546/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and effectiveness of the study drug
known as abemaciclib in participants with hormone receptor positive breast cancer, non-small
cell lung cancer (NSCLC), or melanoma that has spread to the brain.
提供机构：
Vivli
创建时间：
2021-01-13
